prof. dr. D.J. (Daan) Touw

professor - Hospital pharmacist - clinical pharmacologist/toxicologist ERT


  1. 2020
  2. DPOG, Westerdijk, K., Desar, I. M. E., Steeghs, N., van der Graaf, W. T. A., van Erp, N. P., ... Mathijssen, A. H. J. (2020). Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose. British Journal of Clinical Pharmacology.
  3. 2019
  4. Zuur, M. A., Veenhof, H., Aleksa, A., Boveneind-Vrubleuskaya, N. V. ., Darmawan, E., Hasnain, M. G., ... Alffenaar, J-W. C. (2019). Quality Assessment of Dried Blood Spots from Tuberculosis Patients from Four Countries. Therapeutic Drug Monitoring, 41(6), 714-718.
  5. Groenland, S. L., Van Eerden, R. A. G., Koolen, S. L., Moes, D. J. A. R., Desar, I. M. E., Touw, D. J., ... Steeghs, N. (2019). Therapeutic drug monitoring of oral anticancer drugs - preliminary results of a prospective study. Annals of Oncology, 30.
  6. van Velzen, A. J., Uges, J. W. F., Heijerman, H. G. M., Arets, H. G. M., Nuijsink, M., van der Wiel-Kooij, E. C., ... Janssens, H. M. (2019). Pharmacokinetics and safety of tobramycin nebulization with the I-neb® and PARI-LC Plus® in children with cystic fibrosis: a randomized, crossover study. British Journal of Clinical Pharmacology, 85(9), 1984-1993.
Previous 1 2 3 4 5 6 7 8 Next

ID: 499077